AIOS Shift to Chronic Metabolic Care

This is the clearest path for AIOS to stop acting like a one drug checkout flow and start acting like a chronic care clinic. The same intake, prescriber review, refill reminders, and pharmacy fulfillment used for GLP-1 weight loss can also support prediabetes, high cholesterol, blood pressure, and sleep apnea over years, which raises revenue per patient and makes the relationship less dependent on whether one specific obesity drug stays hot or gets cheaper.

• AIOS already runs a recurring care loop, not a one time consult. Patients complete an online questionnaire, a licensed prescriber reviews eligibility, medication ships monthly, and dose titration and refill management happen in the same workflow. That makes adjacent metabolic conditions operationally close to the current product, not a new service line from scratch.
  1 sacra 2 sacra
• The economic reason to broaden care is margin protection. In the UK, Bolt sells branded GLP-1s at cost and keeps pharmacy like gross margins of about 20%, far below the 65% to 80% margins seen at Ro and Hims & Hers when they control more of the fulfillment economics. More conditions and longer treatment arcs let AIOS earn more from each acquired patient without relying on markup from one branded drug.
  1 sacra 2 sacra 6 sacra 7 sacra
• The clinical adjacency is real, not theoretical. Oral Wegovy was approved in the UK on June 11, 2026, which widens the funnel to patients who do not want injections, and obesity drugs are already extending into related disease states, including FDA approval of tirzepatide for obstructive sleep apnea in adults with obesity. That points toward a broader metabolic care bundle built around the same patient base.
  3 gov 4 boltpharmacy 5 fda

The next step is a broader obesity centered clinic where GLP-1 prescribing is the entry point and ongoing metabolic management becomes the core business. As oral drugs expand access and obesity medicines pick up more adjacent indications, the winners will be the platforms that keep patients in care longest and attach the most services around each prescription.